Cytopia Limited are to present data on its JAK2 inhibitor program at two important scientific meetings this month – the Hematological Society of Australia and New Zealand and the ‘Drug Dis… more →
Kinase Newssilico wrote 2 months ago: Cytopia has announced that Cytopia and YM BioSciences have signed an exclusive and binding agreement … more →
crimsoncanary wrote 1 year ago: Cytopia Limited are to present data on its JAK2 inhibitor program at two important scientific meetin … more →
crimsoncanary wrote 1 year ago: Cytopia have announced that it will be presenting data on its JAK2 program at the Philadelphia ACS m … more →
crimsoncanary wrote 1 year ago: Cytopia have appointed a Study chair at the Mayo Clinic in preparation of Phase I JAK2 trials for my … more →
crimsoncanary wrote 1 year ago: Cytopia Limited has announced that they will present details of its FMS kinase program at the Protei … more →
crimsoncanary wrote 1 year ago: Cytopia and Cancer Therapeutics CRC have initiated a collaboration t aimed at leveraging Cytopia’s e … more →
Mike wrote 1 year ago: Cytopia Limited (ASX: CYT) has commenced dosing patients in the first of a suite of Phase II clinica … more →